ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Susana Pascoal et al.|Cancer Research|2023Cited by 24
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Verena Paulitschke|Clinical Proteomics|2018Cited by 19
Suppl. Figure S14 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Rebekka Wegmann et al.|Unknown|2023Cited by 0